Abstract:261 Objectives: Recent years saw the ever-increasing assembly of DNA nanostructures, especially a variety of DNA origami nanostructures (DNA origami, for short), for versatile applications such as nanomotors, nanocomputers, and bio-analysis. Researchers also envision the broad biomedical application of DNA origami in living animals due to its inherent biocompatibility. However, the intrinsic biodistribution and pharmacokinetics of DNA origami in animals has yet to be established. Herein, we apply positron emission tomography (PET) imaging to monitor the distribution of DNA origami, revealing its kidney targeting behavior in mice. Furthermore, we discovered the protection properties of DNA origami nanostructures for mice with acute kidney injury (AKI). Methods: Rectangular DNA origami (Rec-origami) was assembled by folding the M13 scaffold strand with sets of short synthetic oligonucleotides. Eight sidearms were designed on each DNA origami for hybridization of Cu-64 (half-life: 12.7 h) labeled single-stranded DNA (64Cu-NOTA-ssDNA) to form 64Cu-Rec-origami. Longitudinal PET imaging of 64Cu-Rec-origami was performed in both healthy and AKI mice for biodistribution studies and kidney targeting evaluation. AKI was induced by intramuscularly injecting 8 mL/kg of 50% glycerol to both hind limbs of the mice. Two hours after the AKI initiation, Rec-origami was intravenously injected for AKI therapy. PBS and unfolded M13 scaffold strand were used as negative controls, and N-acetyl cysteine (NAC) was applied as a positive control. The therapeutic effect was validated by 68Ga-EDTA dynamic PET, blood levels of creatinine and blood urea nitrogen, and kidney tissue staining. Results: PET imaging revealed that Rec-origami exhibited exclusive renal accumulation at 3 and 12 h after intravenous injection. M13, the unfolded counterpart of DNA origami, showed predominant liver uptake, indicating that only well-folded DNA origami can localize in the kidneys in vivo. Rec-origami was found therapeutically effective at the dose of 10 µg per mouse, as validated by dynamic PET imaging, serum tests, and kidney tissue staining. Most importantly, the treatment dose of Rec-origami was more than 400 times lower than that of NAC, which was about 4.2 mg per mouse. Conclusion: By using PET imaging, we were able to identify the renal targeting properties of DNA origami in both healthy and AKI mice. The localization of DNA origami in the kidneys may serve as protectants against AKI induced by 50% glycerol in vivo. Moreover, the applied dose of Rec-origami was more than 400 times lower than a commonly used antioxidant (NAC), suggesting the promising role of DNA origami nanostructures for kidney related diseases in the future.

Role of Deoxyribonucleic Acid Origami for Alleviating Kidney and Liver Injury in Diabetic Sepsis

A DNA-Based and Bifunctional Nanomedicine for Alleviating Multi-Organ Injury in Sepsis under Diabetic Conditions

Inhibiting DNA Methylation Improves Survival in Severe Sepsis by Regulating NF-κB Pathway.

DNA Origami Nanostructures Can Exhibit Preferential Renal Uptake and Alleviate Acute Kidney Injury.

Deoxyribonuclease I Alleviates Septic Liver Injury in a Rat Model Supported by Venoarterial Extracorporeal Membrane Oxygenation

SRS 16-86 promotes diabetic nephropathy recovery by regulating ferroptosis

Protection of resveratrol on acute kidney injury in septic rats

Resveratrol Protects Against Post-Contrast Acute Kidney Injury in Rabbits With Diabetic Nephropathy

Preferential Renal Uptake of DNA Origami Nanostructures Protects Mice from Acute Kidney Injury

SIRT1/3 Activation by Resveratrol Attenuates Acute Kidney Injury in a Septic Rat Model

#2524 RESOLVIN D1 ATTENUATES SEPSIS INDUCED ACUTE KIDNEY INJURY TARGETING MITOCHONDRIA AND NF-κB SIGNALING PATHWAY

GYY4137, a H2S donor, ameliorates kidney injuries in diabetic mice by modifying renal ROS-associated enzymes

DNA Origami Enhanced Cytokine Immunotherapy for Alleviating Renal Ischemia-Reperfusion Injury

The Role of ALDH2 in Sepsis and the To-Be-Discovered Mechanisms.

A Protective Role of Renalase in Diabetic Nephropathy.

Sequential Therapy of Acute Kidney Injury with a DNA Nanodevice

Resolvin D1 attenuates sepsis induced acute kidney injury targeting mitochondria and NF-κB signaling pathway

SB-525334 ameliorates renal injury in diabetic kidney disease mouse model via suppressing inflammation

Investigating the effect of dehydromiltirone on septic AKI using a network pharmacology method, molecular docking, and experimental validation

Neutrophil membrane-mimicking nanodecoys with intrinsic anti-inflammatory properties alleviate sepsis-induced acute liver injury and lethality in a mouse endotoxemia model

DMDD, isolated from Averrhoa carambola L., ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-autophagy crosstalk